Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592592 · ClinicalTrials.gov registry record · NA
Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT00592592: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00592592 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592592, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The main purpose of this study is to see if using proton beam radiation therapy instead of photon beam radiation therapy can reduce side effects from radiation treatment for rhabdomyosarcoma. Photon beam radiation is the standard type of radiation for treating most rhabdomyosarcoma and many other types of cancer. Photon beam radiation enters the body and passes through healthy tissue, encounters the tumor, then leaves the body through healthy tissue. A beam of proton radiation enters the body and passes through healthy tissue, encounters tumor, but then stops. This means that less healthy tissue is affected by proton beam radiation than by photon beam radiation.
Interventions
- RADIATION Proton Beam Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2004-10 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592592
The ClinicalTrials.gov registry entry for NCT00592592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Beam Radiation is the first listed.
NCT00592592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00592592 about?
NCT00592592 is a clinical study titled "Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma". The main purpose of this study is to see if using proton beam radiation therapy instead of photon beam radiation therapy can reduce side effects from radiation treatment for rhabdomyosarcoma. Photon beam radiation is the standard type of radiation for treating most rhabdomyosarcoma and many other ty...
What is the current status of trial NCT00592592?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2004-10. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00592592?
The interventions under investigation include: Proton Beam Radiation (RADIATION).
Who is sponsoring clinical trial NCT00592592?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.